NVIV
- InVivo Therapeutics Holdings Corp.
()
Overview
Company Summary
InVivo Therapeutics Holdings Corp. (NVIV) is a biotechnology company that focuses on developing and commercializing novel therapies for patients suffering from neurological disorders.
The primary focus of InVivo Therapeutics is on developing and advancing a breakthrough technology called the Neuro-Spinal Scaffold. This scaffold is an investigational bioresorbable polymer device that is surgically implanted at the injury site of patients with acute spinal cord injuries (SCI). The device serves as a physical framework to provide structural support to the injured spinal cord, allowing the cells to grow and regenerate.
In addition to its flagship product, InVivo Therapeutics also engages in extensive research and development activities to explore potential applications of their technology platform in other neurological disorders. They work on developing additional products and therapies that can aid in neuroprotection, tissue regeneration, and functional recovery after severe spinal cord injuries.
The ultimate goal of InVivo Therapeutics is to improve the quality of life for patients suffering from spinal cord injuries and other neurological disorders by providing innovative and effective treatments. The company seeks to leverage its scientific expertise, clinical research, and partnerships to advance the field of regenerative medicine and transform patient care in the realm of neurological disorders.